Gelonade Marijuana Strain

Sativa Dominant Hybrid Strain Sativa Dominant Hybrid 70% Sativa / 30% Indica

THC: 22% - 26%

Gelonade is a sativa dominant hybrid strain created through crossing the infamous Lemon Tre X Gelato #41 strains. Looking for a super delicious flavor and a long-lasting head-heavy high? You've found it with Gelonade. This baby brings on the lip-puckering taste, with a sour citrus lemon taste that's accented by hints of vanilla cookies upon exhale. The aroma is just as delightful, with a sweet vanilla overtone that turns sour and citrusy as the nugs are broken apart and burned away. The Gelonade high is just as amazing as the flavor, with eye-opening effects that are euphoric and pretty arousing in nature. You'll feel a tingle behind the eyes and in the back of the neck almost as soon as you exhale, slowly inching its way forward throughout the rest of your mind and leaving you feeling lifted and energized. An expansive euphoria comes next, launching itself through your entire being and leaving you feeling totally at ease with the world around you. In combination with its super high 22-26% average THC level, Gelonade is often chosen to treat those suffering from conditions such as chronic stress or anxiety, depression, chronic fatigue and chronic pain. This bud has grape-shaped minty green thick nugs with furry orange hairs and a coating of frosty purple-tinted white crystal trichomes.
Roll over the stars, then click to rate.
Why write a strain review?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.Post Review

Gelonade by Honeydew Farms is a sun grown Sativa Dominate Hybrid containing 23% THC. Solid pear green buds with lots of thin short brown pistils & small fine crystal trichomes. Smells & tastes of sour tangy citrus lemon. Effects were a happy energized head high. Strains lineage is Lemon Tree & Gelato #41. First time I finally had a Honeydew Farms product & it won’t be the last! Great bang for your buck! Enjoy your green privilege :)

Trending Articles
Loading...